Entera Bio Ltd reports results for the quarter ended in June - Earnings Summary

Entera Bio

16/08/2021 12:12

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted loss
of 21 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 12 cents per share.
* Revenue rose 109.6% to $109.00 thousand from a year ago; 
analysts expected $86.50 thousand. 
* Entera Bio Ltd's reported EPS for the quarter was a loss of 21
cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Entera Bio Ltd shares had fallen by 9.7% this quarter and
gained 400.0% so far this year.
* The company reported a quarterly loss of $5.15 million.
* Wall Street's median 12-month price target for Entera Bio Ltd
is $12.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 11:12 a.m.  ​All
figures in US dollars unless otherwise stated